Nonselective Beta-Blockers May Improve Outcomes in Ovarian Cancer
Women with cardiovascular conditions (CVCs) and ovarian cancer had better 2-year survival if they received a nonselective beta blocker (NSBB) at or around the time of cancer surgery, a review of medical records showed. Two-year postoperative survival was 80% in the patients who received NSBBs versus 69% for those who did not receive NSBBs. The […]